Glenmark Pharma becomes part of SBTi, sets GHG emission targets for FY2035
Express Pharma
MAY 31, 2023
Glenmark Pharmaceuticals has joined the Science Based Targets initiative (SBTi) business ambition for well below 2°C. A company statement informed, “The SBTi’s has approved Glenmark’s commitment to reduce its absolute scope 1 and 2 GHG emissions by 35 per cent (from an FY2021 base year) by FY2035.
98 
Let's personalize your content